MarketWatch.com - Top Stories

Republicans voted to lift the SALT cap. These taxpayers...

The bill lifts the cap from a flat $10,000 to $15,000 for individuals and $30,00...

Warren Buffett says he’ll be ‘useful’ at Berkshire ‘if ...

The more years that Berkshire gets out of Greg Abel, the incoming CEO, the bette...

Has the stock market’s epic rebound come too far, too f...

Stocks have gone from deeply oversold to overbought in record time. Some on Wall...

Caught in the Newark airport chaos? Here’s what airline...

Travelers flying through Newark are experiencing turbulence before they even mak...

Has the epic rebound in U.S. stocks come too far, too f...

Stocks have gone from deeply oversold to overbought in record time. Some on Wall...

Airbnb wants to be an ‘anything’ app. The debate for in...

Airbnb has rolled out an extensive new effort to make services from professional...

UnitedHealth sees a longtime bull throw in the towel af...

An analyst reluctantly downgraded UnitedHealth’s stock, as the price plunge and ...

What is AI really giving back to tech investors? Here’s...

AI boosters cling to fanciful forecasts — even if meaningful revenue and product...

Do you qualify for the tax breaks in the GOP’s big bill...

The fine print on President Donald Trump’s “big, beautiful” tax and spending bil...

Nvidia, AMD extend stock gains. Why the AI trade is roa...

Nvidia’s partnership with Saudi Arabia’s Humain could help offset some of its re...

Stock-market recovery suggests equities must fall this ...

Trump’s partial tariff pause could suggests a floor on how low equities can go b...

Newly issued eToro shares jump in Nasdaq debut. It’s a ...

The trading platform’s stock is on a run in its first day of trading, elevating ...

Stock-market recovery suggests stocks must fall this fa...

Trump’s partial tariff pause could suggests a floor on how low equities can go b...

Why are Republican senators fighting against federal bu...

Sen. Josh Hawley of Missouri is among the Republicans whose states need Uncle Sa...

This biotech’s stock rockets on oral obesity-drug partn...

Novo Nordisk looks to harness Septerna’s broader GPCR drug pathways, which inclu...

I’m 90, and the RMDs and taxes on my $1.5 million are h...

If you’re leaving money to heirs, you need to consider more than just your own s...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.